Scott Claire, de Barra Mícheál, Johnston Marie, de Bruin Marijn, Scott Neil, Matheson Catriona, Bond Christine, Watson Margaret C
Dental Clinical Effectiveness, NHS Education for Scotland, Dundee, UK
Life Sciences, Brunel University London, Middlesex, UK.
BMJ Open. 2020 Sep 15;10(9):e036500. doi: 10.1136/bmjopen-2019-036500.
The aim of this study was to identify which behaviour change techniques (BCTs) were present in intervention and control groups of randomised controlled trials (RCTs) included in a Cochrane systematic review.
The RCTs included were conducted in community, primary and/or ambulatory-care settings.
The data set was derived from 86 RCTs from an interim update of the Cochrane review of the effectiveness of pharmacist services on non-hospitalised patient outcomes.
The primary outcome was the identification of BCTs scheduled for delivery in intervention and control groups of the RCTs. The secondary outcome measure was to identify which BCTs are not being utilised in intervention and control groups of the RCTs.
The intervention and control groups included 31 and 12 BCTs, respectively. The number of identifiable BCTs/study ranged from 0 to 12 in the intervention groups (mean 3.01 (SD 2.4)) and 0 to 6 in the control groups (mean 0.38 (SD 0.84)). The most commonly identified BCTs in the intervention groups were: instruction on how to perform the behaviour (55%, n=47) (also the most common BCT in control groups); problem solving (29%, n=25); information about health consequences (24%, n=21); social support (practical) (24%, n=21); and social support (unspecified) (23%, n=20) (the second most common BCT in control groups). Thirteen trials had no identifiable BCTs in either group.
The pharmacist interventions presented in this study did not use the full range of available BCTs. Furthermore, the reporting of BCTs was incomplete for both intervention and control groups, thereby limiting the utility and reproducibility of the interventions. Future interventions should be designed and reported using relevant taxonomies and checklists for example, BCT taxonomy and TIDieR (the template for intervention description and replication).
本研究旨在确定Cochrane系统评价纳入的随机对照试验（RCT）的干预组和对照组中存在哪些行为改变技术（BCT）。
纳入的RCT在社区、初级和/或门诊护理环境中进行。
数据集来自Cochrane关于药剂师服务对非住院患者结局有效性评价中期更新中的86项RCT。
主要结局是确定RCT干预组和对照组计划实施的BCT。次要结局指标是确定RCT干预组和对照组未使用的BCT。
干预组和对照组分别包括31种和12种BCT。干预组中可识别的BCT/研究数量范围为0至12（平均3.01（标准差2.4）），对照组为0至6（平均0.38（标准差0.84））。干预组中最常识别的BCT是：如何进行该行为的指导（55%，n = 47）（也是对照组中最常见的BCT）；问题解决（29%，n = 25）；健康后果信息（24%，n = 21）；社会支持（实际）（24%，n = 21）；以及社会支持（未明确说明）（23%，n = 20）（是对照组中第二常见的BCT）。13项试验在两组中均未识别出BCT。
本研究中呈现的药剂师干预措施未使用所有可用的BCT。此外，干预组和对照组中BCT的报告均不完整，从而限制了干预措施的实用性和可重复性。未来的干预措施应使用相关分类法和清单进行设计和报告，例如BCT分类法和TIDieR（干预描述与复制模板）。
